Physician profile
Paul Henson
NPI 1699722892
$4,653.72
in general payments reported to CMS, 2019-2025
48 companies · $84.46 in 2025
The $84.46 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $301 · 2021: $598 · 2022: $1,215 · 2023: $854 · 2024: $874 · 2025: $84.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,811.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $608.44 | 2019-2024 | |
| Astellas Pharma US INC | $470.18 | 2019-2023 | Myrbetriq |
| Urovant Sciences INC | $308.83 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $294.82 | 2023-2024 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $265.32 | 2020-2024 | Jelmyto |
| Boston Scientific Corporation | $253.76 | 2019-2025 | General - Erectile Dysfunction, Lithovue, Lumenis Pulse 120h |
| Pfizer INC. | $253.31 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $232.39 | 2019-2023 | |
| Procept Biorobotics Corporation | $187.99 | 2019-2024 | Aquabeam System |
| Teleflex LLC | $135.69 | 2022-2024 | Urolift |
| Tolmar Pharmaceuticals, INC. | $132.63 | 2019-2022 | |
| Innovation Technologies INC | $94.44 | 2021 | |
| Janssen Biotech, INC. | $92.25 | 2019-2021 | |
| Rochester Medical Corporation | $86.97 | 2022 | |
| Agiliti Surgical, INC. | $85.01 | 2023-2024 | Sonablate Hifu, Koelis Trinity Fusion Biopsy System, Soltive Superpulsed Laser |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Henson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.